Stay updated on Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.

Latest updates to the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, signaling a minor update to the study record page. This change affects only page metadata/display and does not alter the study content.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This reflects a new revision of the page tracked by the site's versioning system.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page's revision was bumped from v3.6.3 to v3.6.4. This signals a deployment update to the page's underlying code or metadata.SummaryDifference0.0%

- Check65 days agoChange DetectedA new revision number was introduced (v3.6.3), replacing the previous v3.6.2; this indicates a small platform/template update with no changes to the study information shown on the page.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page shows a new revision label, updating from v3.6.0 to v3.6.2. This indicates a software/build version change rather than a change to study data or page content.SummaryDifference0.0%

- Check86 days agoChange DetectedRecruitment has been closed on this study page, indicating that enrollment is no longer being sought. New help sections have been added to guide readers on how to interpret the study record and how to join a study, and the page’s revision tag has been updated to v3.6.0 with a minor heading formatting adjustment to Intervention/Treatment.SummaryDifference0.4%

Stay in the know with updates to Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.